CYNTHIA MCNEILL: Open Payments
NPI 1891294633 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,101 in 123 payments from 13 companies in 2025. Trend: 2023 $1,459 · 2024 $1,583 · 2025 $2,101
Food & beverage: $2,101
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 35 | $571 |
| ABBVIE INC. | 26 | $258 |
| Neurocrine BioSciences, Inc. | 9 | $239 |
| Alkermes, Inc. | 11 | $238 |
| Otsuka America Pharmaceutical, Inc. | 13 | $185 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $153 |
| Vanda Pharmaceuticals Inc. | 6 | $152 |
| Lundbeck LLC | 4 | $75 |
| Janssen Pharmaceuticals, Inc | 2 | $73 |
| Luye Pharma (USA) Ltd. | 2 | $54 |
Products named: UZEDY, VRAYLAR, INGREZZA, ARISTADA, AUSTEDO XR, CAPLYTA, FANAPT, ABILIFY MAINTENA.
Industry payments across GA — which companies pay providers there.
